Click here for more information about laboratory operations and procedures
If you have additional questions regarding this test, please call: 415-353-1667
Parvovirus B19 DNA
|Method||Quantitative real time PCR|
|Amount to Collect||
|Sample type||EDTA plasma, amniotic fluid, bone marrow (acceptable but plasma preferred)|
|Processing notes||Blood:Centrifuge blood and transfer plasma to a sterile tube. Freeze at -70C and ship to ViraCor on dry ice.
Amniotic fluid: Freeze at -70C and ship to ViraCor on dry ice.
Bone marrow: Store and ship to ViraCor at room temperature. Do not centrifuge or freeze. Specimen must be received at ViraCor within 96 hrs of collection.
ViraCor test code: 1500
Note: 1 IU = 0.73 copies/mL
|Normal range||Not detected|
|Critical value||Positive result, unless patient has a previous positive result in the prior 3 months.|
|Synonyms||Parvovirus PCR; Parvovirus B19 PCR|
|Stability||Room temperature 4 days, plasma or amniotic fluid frozen at -70C 1 month.|
|Turn around times||1-3 days after receipt by reference laboratory.|
|Additional information||Performed upon blood to determine whether parvovirus infection is the cause of anemia in patients who have an unexplained marked decrease in erythroid precursor cells in bone marrow or a low peripheral reticulocyte count.
The test may also be performed upon amniotic fluid to determine whether parvovirus infection
in pregnancy is the cause of hydrops fetalis.
Detects the presence of Parvovirus B19 in cell free plasma by amplifying viral genomic DNA through Real Time PCR technology.
This assay was developed and the performance characteristics were determined at ViraCor. This test is not FDA approved; however, the test is performed in a CLIA certified laboratory and approval from the FDA is not required.
Specimens are processed and results reported by Microbiology.
|Last Updated||5/22/2013 11:56:33 AM|